(SPA, BLRX, SURW) CRWENewswire Stocks In Action

  • Uploaded by Karmastock on Feb 6, 2012
  • Views: 109

BioLineRx Ltd BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.



Show Description Hide Description